Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01492361
Brief Title: A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event. (REDUCE-IT)

First Submitted : December 13, 2011
First Submitted that Met QC Criteria : December 13, 2011
First Posted : December 15, 2011 (Estimate)

Certification/Extension First Submitted : June 4, 2019
Certification/Extension First Submitted that Met QC Criteria : June 4, 2019
Certification/Extension First Posted : June 6, 2019

Last Update Submitted that Met QC Criteria : June 4, 2019
Last Update Posted : June 6, 2019